Anti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives.

S Rath; Johanna Liebl; R Fürst; A Ullrich; J L Burkhart; U Kazmaier; J Herrmann; Rolf Müller; M Günther; L Schreiner; E Wagner; A M Vollmar; S Zahler

doi:10.1111/j.1476-5381.2012.02037.x

Anti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives.

S Rath, Johanna Liebl, R Fürst, A Ullrich, J L Burkhart, U Kazmaier, J Herrmann, Rolf Müller, M Günther, L Schreiner, E Wagner, A M Vollmar, S Zahler

Research output: Contribution to journal › Original Article › peer-review

40 Citations (Web of Science)

Original language	English
Pages (from-to)	1048-1061
Journal	BRITISH JOURNAL OF PHARMACOLOGY
Volume	167
Issue number	5
DOIs	https://doi.org/10.1111/j.1476-5381.2012.02037.x
Publication status	Published - 2012

Keywords

IN-VIVO
INHIBIT ANGIOGENESIS
ARRIVE GUIDELINES
MICROTUBULES
ANTICANCER
AGENTS
MYXOBACTERIA
DYNAMICS
PEPTIDE
TARGET

Access to Document

10.1111/j.1476-5381.2012.02037.x

Cite this

Rath, S., Liebl, J., Fürst, R., Ullrich, A., Burkhart, J. L., Kazmaier, U., Herrmann, J., Müller, R., Günther, M., Schreiner, L., Wagner, E., Vollmar, A. M., & Zahler, S. (2012). Anti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives. BRITISH JOURNAL OF PHARMACOLOGY , 167(5), 1048-1061. https://doi.org/10.1111/j.1476-5381.2012.02037.x

Rath, S ; Liebl, Johanna ; Fürst, R et al. / Anti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives. In: BRITISH JOURNAL OF PHARMACOLOGY 2012 ; Vol. 167, No. 5. pp. 1048-1061.

@article{be35af296809402e84450e52a2224815,

title = "Anti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives.",

keywords = "IN-VIVO, INHIBIT ANGIOGENESIS, ARRIVE GUIDELINES, MICROTUBULES, ANTICANCER, AGENTS, MYXOBACTERIA, DYNAMICS, PEPTIDE, TARGET",

author = "S Rath and Johanna Liebl and R F{\"u}rst and A Ullrich and Burkhart, {J L} and U Kazmaier and J Herrmann and Rolf M{\"u}ller and M G{\"u}nther and L Schreiner and E Wagner and Vollmar, {A M} and S Zahler",

year = "2012",

doi = "10.1111/j.1476-5381.2012.02037.x",

language = "English",

volume = "167",

pages = "1048--1061",

journal = "BRITISH JOURNAL OF PHARMACOLOGY ",

issn = "0007-1188",

number = "5",

}

Rath, S, Liebl, J, Fürst, R, Ullrich, A, Burkhart, JL, Kazmaier, U, Herrmann, J, Müller, R, Günther, M, Schreiner, L, Wagner, E, Vollmar, AM & Zahler, S 2012, 'Anti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives.', BRITISH JOURNAL OF PHARMACOLOGY , vol. 167, no. 5, pp. 1048-1061. https://doi.org/10.1111/j.1476-5381.2012.02037.x

Anti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives. / Rath, S; Liebl, Johanna; Fürst, R et al.
In: BRITISH JOURNAL OF PHARMACOLOGY , Vol. 167, No. 5, 2012, p. 1048-1061.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Anti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives.

AU - Rath, S

AU - Liebl, Johanna

AU - Fürst, R

AU - Ullrich, A

AU - Burkhart, J L

AU - Kazmaier, U

AU - Herrmann, J

AU - Müller, Rolf

AU - Günther, M

AU - Schreiner, L

AU - Wagner, E

AU - Vollmar, A M

AU - Zahler, S

PY - 2012

Y1 - 2012

KW - IN-VIVO

KW - INHIBIT ANGIOGENESIS

KW - ARRIVE GUIDELINES

KW - MICROTUBULES

KW - ANTICANCER

KW - AGENTS

KW - MYXOBACTERIA

KW - DYNAMICS

KW - PEPTIDE

KW - TARGET

U2 - 10.1111/j.1476-5381.2012.02037.x

DO - 10.1111/j.1476-5381.2012.02037.x

M3 - Original Article

C2 - 22595030

SN - 0007-1188

VL - 167

SP - 1048

EP - 1061

JO - BRITISH JOURNAL OF PHARMACOLOGY

JF - BRITISH JOURNAL OF PHARMACOLOGY

IS - 5

ER -

Rath S, Liebl J, Fürst R, Ullrich A, Burkhart JL, Kazmaier U et al. Anti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives. BRITISH JOURNAL OF PHARMACOLOGY . 2012;167(5):1048-1061. doi: 10.1111/j.1476-5381.2012.02037.x